MRFRの分析によると、じんましん治療の市場規模は2022年に1.82 (10億ドル) と推定されました。この市場は2023年の1.95 (10億ドル) から2032年までに3.5 (10億ドル) に成長し、予測期間 (2024-2032) のCAGRは約6.73% になると予想されます。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. HIVES TREATMENT MARKET, BY TREATMENT TYPE (USD BILLION)
6.1. Antihistamines
6.2. Corticosteroids
6.3. Biologics
6.4. Omalizumab
7. HIVES TREATMENT MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
7.1. Oral
7.2. Injectable
7.3. Topical
8. HIVES TREATMENT MARKET, BY APPLICATION (USD BILLION)
8.1. Chronic Urticaria
8.2. Acute Urticaria
8.3. Physical Urticaria
9. HIVES TREATMENT MARKET, BY END USER (USD BILLION)
9.1. Hospitals
9.2. Homecare Settings
9.3. Specialty Clinics
10. HIVES TREATMENT MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Hives Treatment Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Hives Treatment Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023
12. COMPANY PROFILES
12.1. Takeda Pharmaceuticals
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Regeneron Pharmaceuticals
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Johnson and Johnson
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. GlaxoSmithKline
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Eli Lilly and Company
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Amgen
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Wockhardt
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Alder BioPharmaceuticals
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Genentech
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Zydus Cadila
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. UCB
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Novartis
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Mylan
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Sanofi
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Boehringer Ingelheim
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 8. US HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 9. US HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 10. US HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 11. US HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 28. UK HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 29. UK HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 30. UK HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 31. UK HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 58. APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 59. APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 60. APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 61. APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 128. MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 129. MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 130. MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 131. MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY TREATMENT TYPE, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA HIVES TREATMENT MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP
LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA HIVES TREATMENT MARKET ANALYSIS
FIGURE 3. US HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 4. US HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 5. US HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 6. US HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 7. US HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 9. CANADA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 10. CANADA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 11. CANADA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 12. CANADA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE HIVES TREATMENT MARKET ANALYSIS
FIGURE 14. GERMANY HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 15. GERMANY HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 16. GERMANY HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 17. GERMANY HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 18. GERMANY HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 20. UK HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 21. UK HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 22. UK HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 23. UK HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 25. FRANCE HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 26. FRANCE HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 27. FRANCE HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 28. FRANCE HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 30. RUSSIA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 31. RUSSIA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 32. RUSSIA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 33. RUSSIA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 35. ITALY HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 36. ITALY HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 37. ITALY HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 38. ITALY HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 40. SPAIN HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 41. SPAIN HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 42. SPAIN HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 43. SPAIN HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 45. REST OF EUROPE HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 46. REST OF EUROPE HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 47. REST OF EUROPE HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 48. REST OF EUROPE HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC HIVES TREATMENT MARKET ANALYSIS
FIGURE 50. CHINA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 51. CHINA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 52. CHINA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 53. CHINA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 54. CHINA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 56. INDIA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 57. INDIA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 58. INDIA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 59. INDIA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 61. JAPAN HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 62. JAPAN HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 63. JAPAN HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 64. JAPAN HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 66. SOUTH KOREA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 67. SOUTH KOREA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 68. SOUTH KOREA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 69. SOUTH KOREA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 71. MALAYSIA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 72. MALAYSIA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 73. MALAYSIA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 74. MALAYSIA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 76. THAILAND HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 77. THAILAND HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 78. THAILAND HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 79. THAILAND HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 81. INDONESIA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 82. INDONESIA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 83. INDONESIA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 84. INDONESIA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 86. REST OF APAC HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 87. REST OF APAC HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 88. REST OF APAC HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 89. REST OF APAC HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA HIVES TREATMENT MARKET ANALYSIS
FIGURE 91. BRAZIL HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 92. BRAZIL HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 93. BRAZIL HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 94. BRAZIL HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 95. BRAZIL HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 97. MEXICO HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 98. MEXICO HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 99. MEXICO HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 100. MEXICO HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 102. ARGENTINA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 103. ARGENTINA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 104. ARGENTINA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 105. ARGENTINA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 107. REST OF SOUTH AMERICA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 108. REST OF SOUTH AMERICA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 109. REST OF SOUTH AMERICA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 110. REST OF SOUTH AMERICA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA HIVES TREATMENT MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 113. GCC COUNTRIES HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 114. GCC COUNTRIES HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 115. GCC COUNTRIES HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 116. GCC COUNTRIES HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 118. SOUTH AFRICA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 119. SOUTH AFRICA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 120. SOUTH AFRICA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 121. SOUTH AFRICA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA HIVES TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
FIGURE 123. REST OF MEA HIVES TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 124. REST OF MEA HIVES TREATMENT MARKET ANALYSIS BY APPLICATION
FIGURE 125. REST OF MEA HIVES TREATMENT MARKET ANALYSIS BY END USER
FIGURE 126. REST OF MEA HIVES TREATMENT MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF HIVES TREATMENT MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF HIVES TREATMENT MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: HIVES TREATMENT MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: HIVES TREATMENT MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: HIVES TREATMENT MARKET
FIGURE 133. HIVES TREATMENT MARKET, BY TREATMENT TYPE, 2024 (% SHARE)
FIGURE 134. HIVES TREATMENT MARKET, BY TREATMENT TYPE, 2019 TO 2032 (USD Billions)
FIGURE 135. HIVES TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 136. HIVES TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2032 (USD Billions)
FIGURE 137. HIVES TREATMENT MARKET, BY APPLICATION, 2024 (% SHARE)
FIGURE 138. HIVES TREATMENT MARKET, BY APPLICATION, 2019 TO 2032 (USD Billions)
FIGURE 139. HIVES TREATMENT MARKET, BY END USER, 2024 (% SHARE)
FIGURE 140. HIVES TREATMENT MARKET, BY END USER, 2019 TO 2032 (USD Billions)
FIGURE 141. HIVES TREATMENT MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. HIVES TREATMENT MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS
